 BCLI | Brainstorm Cell Therapeutics Inc. Company profile
Company profileBrainStorm (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinsonâs Disease (PD).
Address1325 Avenue of Americas Videos about Brainstorm Cell Therapeutics Inc. | NotesJump to (Finance sites)         ResearchInvestor pagebrainstormcell.gcs-web.comIf you are looking for News & events, Press Release, they are available on their Investors Relationssite. Their Official Profiles  Peers / Similar stocks Other stocks            Support this projectIf you want to help pay for server cost or for improving this tool. You can send it via Paypal. Social MediaRecommended Books Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals. |
